• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropanes

Recent Advances in the Study of Benzeneethanol, 4-chloro-α,3,5-trimethyl- (CAS: 1823321-85-2): A Comprehensive Research Brief

Benzeneethanol, 4-chloro-α,3,5-trimethyl- (CAS: 1823321-85-2) is a synthetic organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and therapeutic interventions. Recent studies have explored its structural properties, biological activities, and potential mechanisms of action, positioning it as a promising candidate for further investigation. This research brief aims to synthesize the latest findings related to this compound, providing a comprehensive overview of its current status in scientific research.

The compound's unique chemical structure, characterized by a chloro-substituted benzene ring and a trimethylated ethanol side chain, has been the focus of several synthetic and analytical studies. Researchers have employed advanced techniques such as nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography (HPLC) to elucidate its molecular configuration and purity. These efforts have been critical in ensuring the reproducibility of studies involving Benzeneethanol, 4-chloro-α,3,5-trimethyl-, as well as in facilitating its use as a reference standard in pharmacological assays.

In the realm of biological activity, recent investigations have highlighted the compound's potential as an antimicrobial and anti-inflammatory agent. In vitro studies have demonstrated its efficacy against a range of bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli, suggesting its utility in addressing antibiotic-resistant infections. Additionally, preliminary data indicate that the compound may modulate key inflammatory pathways, such as the NF-κB signaling cascade, which could have implications for the treatment of chronic inflammatory diseases.

Further research has explored the pharmacokinetic and toxicological profiles of Benzeneethanol, 4-chloro-α,3,5-trimethyl-. Animal studies have provided insights into its absorption, distribution, metabolism, and excretion (ADME) properties, revealing favorable bioavailability and a manageable safety profile at therapeutic doses. However, challenges remain in optimizing its formulation to enhance stability and delivery, particularly for oral administration. These findings underscore the need for continued research to fully realize the compound's therapeutic potential.

The synthesis and scale-up of Benzeneethanol, 4-chloro-α,3,5-trimethyl- have also been areas of active investigation. Recent advancements in green chemistry have enabled more sustainable and efficient production methods, reducing the environmental impact associated with its synthesis. These innovations are expected to facilitate larger-scale production, making the compound more accessible for preclinical and clinical studies.

In conclusion, Benzeneethanol, 4-chloro-α,3,5-trimethyl- (CAS: 1823321-85-2) represents a compound of significant interest in the chemical biology and pharmaceutical fields. Its demonstrated biological activities, coupled with ongoing improvements in synthesis and formulation, position it as a promising candidate for further development. Future research should focus on elucidating its mechanisms of action, optimizing its pharmacological properties, and advancing it through the drug development pipeline. This brief serves as a timely update on the current state of knowledge surrounding this compound, highlighting both its potential and the challenges that lie ahead.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)